Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Terryl Hartman"'
Publikováno v:
International Journal of Breast Cancer, Vol 2013 (2013)
Studies have shown inconsistent results regarding the association between dietary factors across the lifespan and breast density and breast cancer in women. Breast density is a strong risk factor for breast cancer, and the mechanism through which it
Externí odkaz:
https://doaj.org/article/813e47cdeca941d89d135eaf1ee90169
Autor:
Hanson, Sara, Munthali, Richard, Micklesfield, Lisa, Lobelo, Felipe, Cunningham, Solveig, Terryl Hartman, Norris, Shane, Stein, Aryeh
Supplemental Figures S1-S3 and Supplemental Tables S1-S8 (DOCX 323 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56a7fe9e90b5997ede7148cbb59e0aad
Autor:
Hanson, Sara, Munthali, Richard, Micklesfield, Lisa, Lobelo, Felipe, Cunningham, Solveig, Terryl Hartman, Norris, Shane, Stein, Aryeh
Questionnaire. (PDF 403 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68c0a7f8d3cebbbf9c367f1b429a9cba
Autor:
Yeunjung, Kim, Jingkai, Wei, Jessica, Citronberg, Terryl, Hartman, Veronika, Fedirko, Michael, Goodman
Publikováno v:
Anticancer research. 35(9)
Epidemiological studies of selenium and vitamin E, two antioxidants hypothesized to reduce prostate cancer risk, have shown no discernible benefit. It has been proposed, however, that tobacco smoking may modify the effect of these nutrients.We perfor
Autor:
Karen, Woodson, Spyros, Triantos, Terryl, Hartman, Philip R, Taylor, Jarmo, Virtamo, Demetrius, Albanes
Publikováno v:
Anticancer research. 22(1A)
We previously reported that daily supplementation with alpha-tocopherol reduced prostate cancer risk in a large, randomized trial, the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. One potential mechanism explaining this is that alp
Autor:
Bercedis Peterson, Richard Sloane, Harvey J. Cohen, Paige E. Miller, Denise C. Snyder, Miriam C. Morey, Terryl Hartman, Wendy Demark-Wahnefried
Publikováno v:
Cancer Prevention Research. 1:B4-B4
B4 Cancer survival rates are ever increasing; currently two-thirds of cancer patients will be alive at least 5 years after diagnosis. Despite these gains, many cancer survivors are left with significant comorbidity and accelerated functional decline.